Target intelligence / Profile preview

RNA polymerase β subunit (β (beta))

Target
β (beta)
Molecular classification
Enzyme (specifically, DNA-directed RNA polymerase subunit)
01

Overview

The RNA polymerase β subunit is a core catalytic component of the bacterial transcription machinery, encoded by the rpoB gene and characterized by a large structural domain (DPBB) that collaborates with the β′ subunit to form the active center for RNA synthesis. It participates in nucleotide incorporation, transcript elongation, and structural rearrangements during transcription. The β subunit is the direct target of rifampicin-class antibiotics, and mutations in its gene are a key mechanism of antimicrobial resistance. The β-subunit's structural and functional role is highly conserved among bacteria, and although its general function is retained in eukaryotic cells, the homologous subunit in eukaryotes is substantially different, supporting the selectivity of antibiotic targeting.

Other names
Beta subunit of RNA polymeraserpoBRNAP β subunitDNA-directed RNA polymerase subunit β
02

Mechanism of action

Drugs such as rifampicin bind to the β-subunit and inhibit its ability to synthesize RNA by stalling the elongation phase of transcription

03

Biological functions

Catalysis of RNA synthesisDNA bindingFormation of the RNA exit channelParticipation in transcription elongation and termination
04

Disease associations

Infection (targeted by antibiotics)Other (mutations in rpoB confer resistance to drugs in bacteria, relevant in tuberculosis and other infectious diseases)
05

Safety considerations

Resistance development (mutations in rpoB lead to drug-resistant bacteria)Off-target effects are generally low because β-subunit structure differs substantially between bacteria and eukaryotes
06

Interacting drugs

Rifampicin

2 more in the full profile.

07

Biomarkers

rpoB gene mutations (biomarker of rifampicin resistance in Mycobacterium tuberculosis and other bacteria)

Beyond the preview

Go deeper on RNA polymerase β subunit (β (beta)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA polymerase β subunit (β (beta)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call